TGTGInsighttelegram intelligenceLIVE / telegram public index
Post content
Post content
Johnson & Johnson Q1 2026 Earnings Adj EPS $2.70 (est $2.69) Sales $24.06B (est $23.66B) Tremfya Rev $1.61B (est $1.41B) Medtech Sales $8.64B (est $8.55B) Darzalex Revenue $3.96B (est $3.84B) Sees FY Adj EPS $11.45 To $11.65, Saw $11.43 To $11.63 Sees FY Adj Oper EPS $11.30 To (@FirstSquaw)